Ac-Devd-AFC
To Order Contact us: bjorn@lembcke.dk
Ac-DEVD-AFC *CAS 201608-14-2* |
|||
| 13401 | AAT Bioquest | 5 mg | EUR 132 |
Z-DEVD-AFC |
|||
| A8753-25 | ApexBio | 25 mg | EUR 456 |
|
Description: Z-DEVD-AFC is a fluorometric substrate for caspase-3 (Km = 9.7µM) and other related caspases. The sequence DEVD is based on PARP cleavage at Asp216 for caspase-3. |
|||
Z-DEVD-AFC |
|||
| A8753-5 | ApexBio | 5 mg | EUR 166 |
|
Description: Z-DEVD-AFC is a fluorometric substrate for caspase-3 (Km = 9.7µM) and other related caspases. The sequence DEVD is based on PARP cleavage at Asp216 for caspase-3. |
|||
Ac-DEVD-CHO |
|||
| HY-P1001 | MedChemExpress | 5mg | EUR 380 |
Ac-DEVD-AMC |
|||
| HY-P1003 | MedChemExpress | 5mg | EUR 257 |
Ac-DEVD-pNA |
|||
| HY-P1006 | MedChemExpress | 25mg | EUR 449 |
Ac-DEVD-CMK |
|||
| C5528-1 | ApexBio | 1 mg | EUR 139 |
|
Description: Ac-DEVD-CMK is a cell-permeable and irreversible caspase-3 inhibitor [1][2][3]. Apoptosis is a process of programmed cell death that occurs in multicellular organisms. |
|||
Ac-DEVD-CMK |
|||
| C5528-5 | ApexBio | 5 mg | EUR 457 |
|
Description: Ac-DEVD-CMK is a cell-permeable and irreversible caspase-3 inhibitor [1][2][3]. Apoptosis is a process of programmed cell death that occurs in multicellular organisms. |
|||
Ac-DEVD-pNA |
|||
| A8744-25 | ApexBio | 25 mg | EUR 282 |
|
Description: Ac-DEVD-pNA is a colorimetric substrate for caspase-3 (Km=9.7µM) and caspases-1, -4, -6, and -7 [1]. Ac is the acetyl group and pNA is p-nitroanilide. Sequence is based on PARP (poly(ADPribose) polymerase) cleavage site Asp216 for caspase-3 |
|||
Ac-DEVD-pNA |
|||
| A8744-5 | ApexBio | 5 mg | EUR 119 |
|
Description: Ac-DEVD-pNA is a colorimetric substrate for caspase-3 (Km=9.7µM) and caspases-1, -4, -6, and -7 [1]. Ac is the acetyl group and pNA is p-nitroanilide. Sequence is based on PARP (poly(ADPribose) polymerase) cleavage site Asp216 for caspase-3 |
|||
Ac-DEVD-CHO |
|||
| B1951-1 | Biovision | EUR 142 | |
Ac-DEVD-CHO |
|||
| B1951-5 | Biovision | EUR 414 | |
Caspase-3 Substrate DEVD-AFC |
|||
| 1007-1000 | Biovision | EUR 642 | |
Caspase-3 Substrate DEVD-AFC |
|||
| 1007-200 | Biovision | EUR 327 | |
Ac-IEPD-AFC |
|||
| A4418-5 | ApexBio | 5 mg | EUR 324 |
|
Description: Peptide sequence shown to be preferred recognition motif for the serine protease granzyme B. Fluorogenic substrate. |
|||
Ac-LEHD-AFC |
|||
| A4419-10 | ApexBio | 10 mg | EUR 355 |
|
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. |
|||
Ac-LEHD-AFC |
|||
| A4419-5 | ApexBio | 5 mg | EUR 216 |
|
Description: Fluorogenic caspase substrate. Analog of the caspase-9 substrate, LEHD-AFC. |
|||
Ac-VEID-AFC |
|||
| A8751-25 | ApexBio | 25 mg | EUR 456 |
|
Description: Ac-VEID-AFC is a fluorogenic substrate of caspase-6 (Km=30?M; Kcat/Km=168000 M-1sec-1) and related cysteine proteases. The sequence is based on the lamin A site of cleavage. |
|||
Ac-VEID-AFC |
|||
| A8751-5 | ApexBio | 5 mg | EUR 166 |
|
Description: Ac-VEID-AFC is a fluorogenic substrate of caspase-6 (Km=30?M; Kcat/Km=168000 M-1sec-1) and related cysteine proteases. The sequence is based on the lamin A site of cleavage. |
|||
Ac-IETD-AFC |
|||
| A8752-25 | ApexBio | 25 mg | EUR 456 |
|
Description: Ac-IETD-AFC is a fluorogenic substrate of caspase-8 and possesses amino aicd sequence IETD which is recognized by caspase-8-mediated proteolysis. It is also a substrate for caspase-3 processing enzyme, caspase-10, and granzyme B. |
|||
Ac-IETD-AFC |
|||
| A8752-5 | ApexBio | 5 mg | EUR 166 |
|
Description: Ac-IETD-AFC is a fluorogenic substrate of caspase-8 and possesses amino aicd sequence IETD which is recognized by caspase-8-mediated proteolysis. It is also a substrate for caspase-3 processing enzyme, caspase-10, and granzyme B. |
|||
Ac-VDVAD-AFC |
|||
| A8757-1 | ApexBio | 1 mg | EUR 145 |
Ac-VDVAD-AFC |
|||
| A8757-10 | ApexBio | 10 mg | EUR 529 |
Ac-VDVAD-AFC |
|||
| A8757-5 | ApexBio | 5 mg | EUR 313 |
Ac-LEVD-AFC |
|||
| A8759-25 | ApexBio | 25 mg | EUR 456 |
Ac-LEVD-AFC |
|||
| A8759-5 | ApexBio | 5 mg | EUR 166 |
Ac-WEHD-AFC |
|||
| A8761-1 | ApexBio | 1 mg | EUR 145 |
Ac-WEHD-AFC |
|||
| A8761-10 | ApexBio | 10 mg | EUR 483 |
Ac-WEHD-AFC |
|||
| A8761-5 | ApexBio | 5 mg | EUR 290 |
Ac-YVAD-AFC |
|||
| A8956-10 | ApexBio | 10 mg | EUR 293 |
|
Description: Ac-YVAD-AFC |
|||
Ac-YVAD-AFC |
|||
| A8956-5 | ApexBio | 5 mg | EUR 180 |
|
Description: Ac-YVAD-AFC |
|||
Ac-WEHD-AFC |
|||
| B2214-25 | Biovision | EUR 675 | |
Ac-WEHD-AFC |
|||
| B2214-5 | Biovision | EUR 207 | |
Ac-IEPD-AFC |
|||
| B2526-25 | Biovision | EUR 838 | |
Ac-IEPD-AFC |
|||
| B2526-5 | Biovision | EUR 251 | |
Ac-Gly-Pro-AFC |
|||
| I-2000.0005 | Bachem | 5.0mg | EUR 200 |
|
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8] |
|||
Ac-Gly-Pro-AFC |
|||
| I-2000.0025 | Bachem | 25.0mg | EUR 708 |
|
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8] |
|||
Ac-Gly-Pro-AFC |
|||
| I-2000.0100 | Bachem | 100.0mg | EUR 2061 |
|
Description: Sum Formula: C19H18F3N3O5; CAS# [886993-02-8] |
|||
Ac-DEVD-CHO, Caspase-3 Inhibitor |
|||
| 10404 | Biotium | 5MG | EUR 307 |
|
Description: Minimum order quantity: 1 unit of 5MG |
|||
Ac-DEVD-CHO, Caspase-3 Inhibitor |
|||
| 10404-1 | Biotium | 1MG | EUR 125 |
|
Description: Minimum order quantity: 1 unit of 1MG |
|||
Ac-Tyr-Val-Ala-Asp-AFC |
|||
| I-1705.0005 | Bachem | 5.0mg | EUR 321 |
|
Description: Sum Formula: C33H36F3N5O10; CAS# [219137-85-6] |
|||
Ac-Tyr-Val-Ala-Asp-AFC |
|||
| I-1705.0025 | Bachem | 25.0mg | EUR 1192 |
|
Description: Sum Formula: C33H36F3N5O10; CAS# [219137-85-6] |
|||
Ac-Asp-Glu-Val-Asp-AFC |
|||
| I-1725.0005 | Bachem | 5.0mg | EUR 321 |
|
Description: Sum Formula: C30H34F3N5O13; CAS# [201608-14-2] |
|||
Ac-Asp-Glu-Val-Asp-AFC |
|||
| I-1725.0025 | Bachem | 25.0mg | EUR 1192 |
|
Description: Sum Formula: C30H34F3N5O13; CAS# [201608-14-2] |
|||
Ac-Leu-Glu-His-Asp-AFC |
|||
| I-1820.0001 | Bachem | 1.0mg | EUR 116 |
|
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net |
|||
Ac-Leu-Glu-His-Asp-AFC |
|||
| I-1820.0005 | Bachem | 5.0mg | EUR 321 |
|
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net |
|||
Ac-Leu-Glu-His-Asp-AFC |
|||
| I-1820.0025 | Bachem | 25.0mg | EUR 1192 |
|
Description: Sum Formula: C33H38F3N7O11; CAS# [210345-03-2] net |
|||
Ac-Leu-Glu-Val-Asp-AFC |
|||
| I-1905.0005 | Bachem | 5.0mg | EUR 393 |
|
Description: Sum Formula: C32H40F3N5O11; CAS# [1092077-23-0] |
|||
Ac-Leu-Glu-Val-Asp-AFC |
|||
| I-1905.0025 | Bachem | 25.0mg | EUR 1482 |
|
Description: Sum Formula: C32H40F3N5O11; CAS# [1092077-23-0] |
|||
Ac-Leu-Glu-Thr-Asp-AFC |
|||
| I-1910.0001 | Bachem | 1.0mg | EUR 126 |
|
Description: Sum Formula: C31H38F3N5O12; CAS# [210345-02-1] |
|||
Ac-Leu-Glu-Thr-Asp-AFC |
|||
| I-1910.0005 | Bachem | 5.0mg | EUR 393 |
|
Description: Sum Formula: C31H38F3N5O12; CAS# [210345-02-1] |
|||
Ac-Lys-Gln-Leu-Arg-AFC |
|||
| I-2005.0001 | Bachem | 1.0mg | EUR 119 |
|
Description: Sum Formula: C35H51F3N10O8; CAS# [1802078-38-1] net |
|||
Ac-Lys-Gln-Leu-Arg-AFC |
|||
| I-2005.0005 | Bachem | 5.0mg | EUR 323 |
|
Description: Sum Formula: C35H51F3N10O8; CAS# [1802078-38-1] net |
|||
Ac-Trp-Glu-His-Asp-AFC |
|||
| I-2010.0001 | Bachem | 1.0mg | EUR 71 |
|
Description: Sum Formula: C38H37F3N8O11; CAS# [210344-99-3] net |
|||
Ac-Trp-Glu-His-Asp-AFC |
|||
| I-2010.0005 | Bachem | 5.0mg | EUR 177 |
|
Description: Sum Formula: C38H37F3N8O11; CAS# [210344-99-3] net |
|||
Ac-DEVD-AMC *CAS 169332-61-0* |
|||
| 13402 | AAT Bioquest | 5 mg | EUR 132 |
Ac-DEVD-CHO *CAS 169332-60-9* |
|||
| 13403 | AAT Bioquest | 1 mg | EUR 132 |
Ac-DEVD-pNA *CAS 189950-66-1* |
|||
| 13405 | AAT Bioquest | 5 mg | EUR 132 |
Ac-IETD-AFC *CAS 211990-57-7* |
|||
| 13410 | AAT Bioquest | 5 mg | EUR 219 |
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC |
|||
| 5-00935 | CHI Scientific | 4 x 5mg | Ask for price |
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC Peptide |
|||
| 20-abx265595 | Abbexa |
|
|
Z-DEVD-AMC |
|||
| 13421 | AAT Bioquest | 5 mg | EUR 176 |
Z-DEVD-pNA |
|||
| 13422 | AAT Bioquest | 5 mg | EUR 132 |
Z-DEVD-FMK |
|||
| HY-12466 | MedChemExpress | 10mg | EUR 393 |
Z-DEVD-FMK |
|||
| A1920-1 | ApexBio | 1 mg | EUR 113 |
|
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
|||
Z-DEVD-FMK |
|||
| A1920-10 | ApexBio | 10 mg | EUR 340 |
|
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
|||
Z-DEVD-FMK |
|||
| A1920-25 | ApexBio | 25 mg | EUR 514 |
|
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
|||
Z-DEVD-FMK |
|||
| A1920-5 | ApexBio | 5 mg | EUR 224 |
|
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
|||
Z-DEVD-FMK |
|||
| A1920-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 293 |
|
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
|||
Z-DEVD-FMK |
|||
| A1920-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death. |
|||
Z-DEVD-pNA |
|||
| A8748-25 | ApexBio | 25 mg | EUR 282 |
|
Description: Z-DEVD-pNA is a colorimetric substrate for caspase-3 with increased cell permeability. Sequence is based on PARP poly(ADP-ribose) polymerase which is clevaved by caspase-3 at the amino acid sequence DEVD[1]. |
|||
Z-DEVD-pNA |
|||
| A8748-5 | ApexBio | 5 mg | EUR 119 |
|
Description: Z-DEVD-pNA is a colorimetric substrate for caspase-3 with increased cell permeability. Sequence is based on PARP poly(ADP-ribose) polymerase which is clevaved by caspase-3 at the amino acid sequence DEVD[1]. |
|||
FITC-DEVD-FMK |
|||
| 9499-100 | Biovision | EUR 359 | |
Biotin-DEVD-FMK |
|||
| 1124-20C | Biovision | EUR 370 | |
Z-DEVD-FMK |
|||
| 1143-1 | Biovision | EUR 316 | |
Z-DEVD-FMK |
|||
| 1143-5 | Biovision | EUR 805 | |
H-Ala-AFC |
|||
| I-1455.0250 | Bachem | 250.0mg | EUR 587 |
|
Description: Sum Formula: C13H11F3N2O3; CAS# [126910-31-4] net |
|||
H-Ala-AFC |
|||
| I-1455.1000 | Bachem | 1.0g | EUR 1698 |
|
Description: Sum Formula: C13H11F3N2O3; CAS# [126910-31-4] net |
|||
FITC-C6-DEVD-FMK |
|||
| 13406 | AAT Bioquest | 1 mg | EUR 480 |
FITC-C6-DEVD-FMK |
|||
| 13408 | AAT Bioquest | 100 ug | EUR 219 |
EZSolution? Q-DEVD-OPh |
|||
| 1178-1 | Biovision | EUR 272 | |
H-Ala-Pro-AFC |
|||
| I-1680.0050 | Bachem | 50.0mg | EUR 563 |
|
Description: Sum Formula: C18H18F3N3O4; CAS# [125791-92-6] |
|||
H-Ala-Pro-AFC |
|||
| I-1680.0250 | Bachem | 250.0mg | EUR 2159 |
|
Description: Sum Formula: C18H18F3N3O4; CAS# [125791-92-6] |
|||
AC-PEG-AC |
|||
| abx085037-10kDa1g | Abbexa | 10 kDa; 1 g | EUR 328 |
AC-PEG-AC |
|||
| abx085037-1kDa1g | Abbexa | 1 kDa; 1 g | EUR 328 |
AC-PEG-AC |
|||
| abx085037-20kDa1g | Abbexa | 20 kDa; 1 g | EUR 328 |
Z-DEVD-ProRed™ 620 |
|||
| 13433 | AAT Bioquest | 1 mg | EUR 306 |
Caspase-3 Substrate DEVD-pNA |
|||
| 1008-1000 | Biovision | EUR 642 | |
Caspase-3 Substrate DEVD-pNA |
|||
| 1008-200 | Biovision | EUR 327 | |
AC-PEG-AC,10K |
|||
| 33-HO009009-10K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
AC-PEG-AC,1K |
|||
| 33-HO009009-1K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
AC-PEG-AC,20K |
|||
| 33-HO009009-20K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
AC-PEG-AC,2K |
|||
| 33-HO009009-2K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
AC-PEG-AC,3.4K |
|||
| 33-HO009009-3.4K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
AC-PEG-AC,5K |
|||
| 33-HO009009-5K | Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
|||
Ac-GPK(Ac)-pNA |
|||
| 5-00556 | CHI Scientific | 4 x 5mg | Ask for price |
Ac-Tyr(Ac)-OH |
|||
| 5-03625 | CHI Scientific | 25g | Ask for price |
Ac-Tyr(Ac)-OH |
|||
| 5-03626 | CHI Scientific | 100g | Ask for price |
Ac-Lys(Ac)-OH |
|||
| E-1775.0001 | Bachem | 1.0g | EUR 126 |
|
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5] |
|||
Ac-Lys(Ac)-OH |
|||
| E-1775.0005 | Bachem | 5.0g | EUR 418 |
|
Description: Sum Formula: C10H18N2O4; CAS# [499-86-5] |
|||
H-Gly-Ala-Pro-AFC |
|||
| I-1700.0025 | Bachem | 25.0mg | EUR 708 |
|
Description: Sum Formula: C20H21F3N4O5; CAS# [219137-81-2] |
|||
H-Gly-Ala-Pro-AFC |
|||
| I-1700.0100 | Bachem | 100.0mg | EUR 2061 |
|
Description: Sum Formula: C20H21F3N4O5; CAS# [219137-81-2] |
|||
Caspase-8 Substrate IETD-AFC |
|||
| 1062-1000 | Biovision | EUR 642 | |
Caspase-8 Substrate IETD-AFC |
|||
| 1062-200 | Biovision | EUR 327 | |
Caspase-6 Substrate VEID-AFC |
|||
| 1069-1000 | Biovision | EUR 642 | |
Caspase-6 Substrate VEID-AFC |
|||
| 1069-200 | Biovision | EUR 327 | |
Caspase-2 Substrate VDVAD-AFC |
|||
| 1071-1000 | Biovision | EUR 642 | |
Caspase-2 Substrate VDVAD-AFC |
|||
| 1071-200 | Biovision | EUR 327 | |
Caspase-9 Substrate LEHD-AFC |
|||
| 1075-1000 | Biovision | EUR 642 | |
Caspase-9 Substrate LEHD-AFC |
|||
| 1075-200 | Biovision | EUR 327 | |
Caspase-5 Substrate WEHD-AFC |
|||
| 1101-1000 | Biovision | EUR 642 | |
Caspase-5 Substrate WEHD-AFC |
|||
| 1101-200 | Biovision | EUR 327 | |
Caspase-1 Substrate YVAD-AFC |
|||
| 1103-1000 | Biovision | EUR 642 | |
Caspase-1 Substrate YVAD-AFC |
|||
| 1103-200 | Biovision | EUR 327 | |
Caspase-4 Substrate LEVD-AFC |
|||
| 1109-1000 | Biovision | EUR 642 | |
Caspase-4 Substrate LEVD-AFC |
|||
| 1109-200 | Biovision | EUR 327 | |